Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002951 · ClinicalTrials.gov registry record · Phase 2
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
A Phase 2 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 53
- Enrollment target
NCT00002951 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 53 participants.
The verdict
NCT00002951, a Phase 2 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 53 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy plus radiation therapy in treating patients with head and neck cancer.
Interventions
- DRUG fluorouracil
- RADIATION radiation therapy
- DRUG hydroxyurea
- PROCEDURE surgical procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 1996-06 |
| Est. Completion | 2006-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002951
The ClinicalTrials.gov registry entry for NCT00002951 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which fluorouracil is the first listed.
NCT00002951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002951 about?
NCT00002951 is a clinical study titled "Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effe...
What is the current status of trial NCT00002951?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 1996-06. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00002951?
The interventions under investigation include: fluorouracil (DRUG), radiation therapy (RADIATION), hydroxyurea (DRUG), surgical procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00002951?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.